Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07426003 · ClinicalTrials.gov registry record · NA
Healthy Volunteers Enteral Nutrition Study (HEN)
A NA study, sponsored by James Lewis.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07426003: Recruiting NA study, sponsored by James Lewis.
NCT07426003 is a NA study that is actively recruiting participants, run by James Lewis. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07426003, a NA study, is actively recruiting participants, sponsored by James Lewis.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This research study is being conducted to determine the effects of enteral nutrition on healthy people. Enteral nutrition for the purpose of this study refers to the use of a specially developed formula taken by mouth that provides all essential nutrition either in the absence of food or to supplement the intake of foods. Enteral nutrition can be used for many reasons, such as to gain or lose weight, to treat food allergies, or to reduce inflammation in certain intestinal diseases. We would like to understand the effects of enteral nutrition in the absence of intestinal inflammation.
Primary Outcome
Number of sitz markers that are present in an abdominal x-ray 72 hours after the participant takes the sitz mark capsule
Interventions
- DIETARY_SUPPLEMENT Kate Farms Peptide 1.5
- OTHER Crohn's disease exclusion diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-06-17 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT07426003 shows while recruiting
NCT07426003 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Kate Farms Peptide 1.5 is the first listed.
NCT07426003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07426003 about?
NCT07426003 is a clinical study titled "Healthy Volunteers Enteral Nutrition Study (HEN)". This research study is being conducted to determine the effects of enteral nutrition on healthy people. Enteral nutrition for the purpose of this study refers to the use of a specially developed formula taken by mouth that provides all essential nutrition either in the absence of food or to suppleme...
What is the current status of trial NCT07426003?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-06-17. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07426003?
The interventions under investigation include: Kate Farms Peptide 1.5 (DIETARY_SUPPLEMENT), Crohn's disease exclusion diet (OTHER).
Who is sponsoring clinical trial NCT07426003?
This trial is sponsored by James Lewis, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07426003's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI